Hospi Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Employees
  • 126
Employees
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $3.49M
Latest Deal Amount
  • Investors
  • 8

Hospi General Information

Description

Developer of a rectal catheter device designed to facilitate rectal administration of liquids or medications. The company's device facilitates the discreet oral flow of medications and is particularly useful for the management of symptoms when a patient has difficulty swallowing or the oral route is compromised, enabling physicians to enhance patient comfort and well-being efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Drug Delivery
Primary Office
  • 39655 Eureka Drive
  • Newark, CA 94560
  • United States
+1 (888) 000-0000

Hospi Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Hospi Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 10-Jun-2020 $3.49M 0000 000.00 Completed Generating Revenue
6. Debt - PPP 05-May-2020 00.000 Completed Generating Revenue
5. Early Stage VC (Series A1) 08-Feb-2017 00.000 00.000 0000 Completed Generating Revenue
4. Accelerator/Incubator 01-Sep-2016 000 Completed Generating Revenue
3. Grant 18-Nov-2014 00000 000 Completed Generating Revenue
2. Early Stage VC (Series A) 24-Mar-2014 $3M $3M 000 Completed Generating Revenue
1. Grant 01-Jan-2013 $150K Completed Generating Revenue
To view Hospi’s complete valuation and funding history, request access »

Hospi Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A1 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 3,100,000 $0.000100 $0.08 $1.03 $1.03 1x $0.99 19.09%
To view Hospi’s complete cap table history, request access »

Hospi Executive Team (2)

Name Title Board Seat Contact Info
Igal Ladabaum Co-Founder, Chief Executive Officer and Board Member
Bradford Macy Co-Founder, President and Board Member
To view Hospi’s complete executive team members history, request access »

Hospi Board Members (7)

Name Representing Role Since
Bradford Macy Hospi Co-Founder, President and Board Member 000 0000
Igal Ladabaum Hospi Co-Founder, Chief Executive Officer and Board Member 000 0000
Ricardo Rosenkranz Hospi Board Member 000 0000
Richard Kashnow Ph.D Hospi Board Member 000 0000
Richard Popp MD Hospi Co-Founder and Chairman 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Hospi Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hospi Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agility Labs Accelerator/Incubator Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
Oscar Schafer Angel (individual) Minority 000 0000 000000 0
Paul Robbins Angel (individual) Minority 000 0000 000000 0
Richard Kashnow Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »